Original document(7 pages)  中文版
    The present invention discloses a Chinese medicine poria chaenomeles fruit capsule and its preparation process. It is made up by using the Chinese medicinal materials of poria, chaenomeles fruit, peach kernel, lotus seed, jujube and black sesame and soyabean isoflavone through a certain preparation process. Its preparation method includes the following steps: cleaning raw material, extraction, pulverizing, granulating and capsulizing. Said Chinese medicine capsule preparation mainly is used for curing the diseases of menopausal syndrome of wonen, irregular menstruation, osteoporosis and mammary maldevelopment, etc. and can obtain obvious therapeutic effect.
Application Number
申请号
200610124609 Application Date
申请日
2006.09.21
Title 名称 Poriacocos-fruictus chaenomelis capsule and its preparing process
Publication Number
公开号
1935011 Publication Date
公开日
2007.03.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A23L1/29;A61K36/076;A23L1/212;A23L1/36;A23L1/28
Applicant(s) Name
申请人
Zhang Zhixiang
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人

  
Method for extracting oil from tea-oil seed by using additive
Recovery of ethylene from catalytic cracking dry gas and preparation of epoxyethane
Mfg. for producing alumina carrier and use thereof
Toilet papers printed with amusement figures and advertisement
Hemostatic capsule and its preparing process
Medical capsule for invigorating function of spleen and its preparing process
Exterior-applied ointment for lossing weight and its preparing process
Liver-spleen capsule and its preparing process
Carrier of ethylene oxide silver catalyst, and its preparation method and application
Method of producing crankshaft oil hole
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.